BCAL Diagnostics Limited (AU:BDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BCAL Diagnostics Limited has announced the issuance of 9,150,000 performance rights as part of an employee incentive scheme. These securities are unquoted and intended for internal use to motivate and retain talent within the company. This move reflects BCAL’s commitment to aligning employee interests with corporate growth objectives.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.